One study examined the effects of a Rad51 genotypes in BRCA1/2 carriers and reported that Rad51 135G>C genotype association with breast cancer risk was greater in BRCA1 carriers with truncating mutations (i.e. 185delAG) [40]. This evidence concerns the gene BRCA1 and breast carcinoma.